During the past decade, GFI Research Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "GFI Research Center" are "Back Pain Lower Back Chronic" (2 trials) and "Diabetes Mellitus, Type II" (1 trials). Many other conditions were trialed in "GFI Research Center" in a lesser frequency.

Most popular intervention types in "GFI Research Center" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Buprenorphine" (1 trials), "Buprenorphine transdermal patch" (1 trials), "Oxycodone Immediate-Release" (1 trials), "Placebo" (1 trials) and "T0903131 Besylate" (1 trials). Other intervention names were less common.

The vast majority of trials in "GFI Research Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "GFI Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in GFI Research Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in GFI Research Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".